Class action status is being sought in a lawsuit filed in the Supreme Court of British Columbia against Eli Lilly on behalf of patients who took the company's anti-psychotic drug Zyprexa. The suit alleges that the company minimized the heath risks of taking Zyprexa, and claims that Zyprexa has been associated with "increased risk of developing diabetes, hyperglycemia, pancreatitis, ketoacidosis and other injuries."
The company is facing 135 product liability suits over Zyprexa in the United States and at least one lawsuit has been filed in Ontario.
Drug Companies Still Peddling Risperdal and Zyprexa for Off-Label Use
Kids Dying from Off-Label use of Antipsychotics
Zyprexa Medicaid Gravy Train Derailed
Drug Marketing Scheme Hits Nation's School System
Kids Dying from Off-Label use of Antipsychotics
Zyprexa Medicaid Gravy Train Derailed
Drug Marketing Scheme Hits Nation's School System
